A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza
- PMID: 17577050
- DOI: 10.1099/jmm.0.47124-0
A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza
Abstract
Acute hypercytokinaemia represents an imbalance of pro-inflammatory and anti-inflammatory cytokines, and is believed to be responsible for the development of acute respiratory distress syndrome and multiple organ failure in severe cases of avian (H5N1) influenza. Although neuraminidase inhibitors are effective in treating avian influenza, especially if given within 48 h of infection, it is harder to prevent the resultant hypercytokinaemia from developing if the patient does not seek timely medical assistance. Steroids have been used for many decades in a wide variety of inflammatory conditions in which hypercytokinaemia plays a role, such as sepsis and viral infections, including severe acquired respiratory syndromes and avian influenza. However, to date, the results have been mixed. Part of the reason for the discrepancies might be the lack of understanding that low doses are required to prevent mortality in cases of adrenal insufficiency. Adrenal insufficiency, as defined in the sepsis/shock literature, is a plasma cortisol rise of at least 9 microg dl(-1) following a 250 microg dose of adrenocorticotropin hormone (ACTH), or reaching a plasma cortisol concentration of >25 microg dl(-1) following a 1-2 microg dose of ACTH. In addition, in the case of hypercytokinaemia induced by potent viruses, such as H5N1, systemic inflammation-induced, acquired glucocorticoid resistance is likely to be present. Adrenal insufficiency can be overcome, however, with prolonged (7-10 or more days) supraphysiological steroid treatment at a sufficiently high dose to address the excess activation of NF-kappaB, but low enough to avoid immune suppression. This is a much lower dose than has been typically used to treat avian influenza patients. Although steroids cannot be used as a monotherapy in the treatment of avian influenza, there might be a potential role for their use as an adjunct treatment to antiviral therapy if appropriate dosages can be determined. In this paper, likely mechanisms of adrenal insufficiency are discussed, drawing from a broad background of literature sources.
Similar articles
-
The threat of avian influenza A (H5N1). Part III: Antiviral therapy.Med Microbiol Immunol. 2007 Dec;196(4):203-12. doi: 10.1007/s00430-007-0048-z. Epub 2007 Apr 12. Med Microbiol Immunol. 2007. PMID: 17431677 Review.
-
Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.Antiviral Res. 2017 Mar;139:41-48. doi: 10.1016/j.antiviral.2016.12.011. Epub 2016 Dec 22. Antiviral Res. 2017. PMID: 28012921
-
An overview of the highly pathogenic H5N1 influenza virus.Virol Sin. 2013 Feb;28(1):3-15. doi: 10.1007/s12250-013-3294-9. Epub 2013 Jan 16. Virol Sin. 2013. PMID: 23325419 Free PMC article. Review.
-
Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.Vaccine. 2007 Oct 16;25(42):7379-84. doi: 10.1016/j.vaccine.2007.08.011. Epub 2007 Aug 24. Vaccine. 2007. PMID: 17870216
-
Identification of Human Case of Avian Influenza A(H5N1) Infection, India.Emerg Infect Dis. 2022 Jun;28(6):1269-1273. doi: 10.3201/eid2806.212246. Emerg Infect Dis. 2022. PMID: 35608874 Free PMC article.
Cited by
-
Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.J Infect. 2008 Sep;57(3):223-8. doi: 10.1016/j.jinf.2008.06.012. Epub 2008 Jul 25. J Infect. 2008. PMID: 18656264 Free PMC article.
-
Mast cell-induced lung injury in mice infected with H5N1 influenza virus.J Virol. 2012 Mar;86(6):3347-56. doi: 10.1128/JVI.06053-11. Epub 2012 Jan 11. J Virol. 2012. PMID: 22238293 Free PMC article.
-
Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor.Emerg Microbes Infect. 2013 Aug;2(8):e54. doi: 10.1038/emi.2013.52. Epub 2013 Aug 21. Emerg Microbes Infect. 2013. PMID: 26038487 Free PMC article.
-
Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm.Immunol Res. 2011 Oct;51(1):15-25. doi: 10.1007/s12026-011-8240-z. Immunol Res. 2011. PMID: 21901448 Review.
-
Chronic heat stress weakened the innate immunity and increased the virulence of highly pathogenic avian influenza virus H5N1 in mice.J Biomed Biotechnol. 2011;2011:367846. doi: 10.1155/2011/367846. Epub 2011 May 29. J Biomed Biotechnol. 2011. PMID: 21687549 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical